Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Maggs

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Diabetologia|May 1, 1996
Can hypoglycaemia be predicted before its onset?D Maggs
The British Journal of Ophthalmology|January 27, 2004
The falcon's stoopI R Schwab, D Maggs
Diabetes, Obesity & Metabolism|May 11, 2007
Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetesD Maggs, I MacDonald, M A Nauck
Diabetes, Obesity & Metabolism|April 19, 2012
Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide*S Paul, J Best, K Klein, et al.
Diabetes, Obesity & Metabolism|January 12, 2012
GLP-1 based therapies: differential effects on fasting and postprandial glucoseM S Fineman, B B Cirincione, D Maggs, et al.
Metabolism: Clinical and Experimental|December 12, 2003
Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysisD Maggs, L Shen, S Strobel, et al.
Journal of Virology|November 23, 2000
Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient miceE Chang, L Galle, D Maggs, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesityN Attia, W V Tamborlane, R Heptulla, et al.
Diabetes, Obesity & Metabolism|November 18, 2003
Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targetsP Hollander, R Ratner, M Fineman, et al.
Diabetes, Obesity & Metabolism|November 27, 2014
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trialM A Abdul-Ghani, C Puckett, C Triplitt, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Diabetologia|May 1, 1996
Can hypoglycaemia be predicted before its onset?D Maggs
The British Journal of Ophthalmology|January 27, 2004
The falcon's stoopI R Schwab, D Maggs
Diabetes, Obesity & Metabolism|May 11, 2007
Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetesD Maggs, I MacDonald, M A Nauck
Diabetes, Obesity & Metabolism|April 19, 2012
Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide*S Paul, J Best, K Klein, et al.
Diabetes, Obesity & Metabolism|January 12, 2012
GLP-1 based therapies: differential effects on fasting and postprandial glucoseM S Fineman, B B Cirincione, D Maggs, et al.
Metabolism: Clinical and Experimental|December 12, 2003
Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysisD Maggs, L Shen, S Strobel, et al.
Journal of Virology|November 23, 2000
Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient miceE Chang, L Galle, D Maggs, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesityN Attia, W V Tamborlane, R Heptulla, et al.
Diabetes, Obesity & Metabolism|November 18, 2003
Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targetsP Hollander, R Ratner, M Fineman, et al.
Diabetes, Obesity & Metabolism|November 27, 2014
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trialM A Abdul-Ghani, C Puckett, C Triplitt, et al.
Pageof 2